Automate Your Wheel Strategy on BSX
With Tiblio's Option Bot, you can configure your own wheel strategy including BSX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BSX
- Rev/Share 11.8826
- Book/Share 15.195
- PB 6.8606
- Debt/Equity 0.5271
- CurrentRatio 1.4502
- ROIC 0.0701
- MktCap 152620062000.0
- FreeCF/Share 1.9449
- PFCF 53.1222
- PE 74.9941
- Debt/Assets 0.2917
- DivYield 0
- ROE 0.0956
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | BSX | Leerink Partners | -- | Outperform | -- | $118 | June 16, 2025 |
| Upgrade | BSX | Needham | Hold | Buy | -- | $113 | April 16, 2025 |
| Upgrade | BSX | Deutsche Bank | Hold | Buy | -- | $108 | Jan. 10, 2025 |
| Downgrade | BSX | Needham | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock?
Published: March 11, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX's shares rise on the back of its innovative product portfolio and impressive value-added acquisition. However, the unfavorable macroeconomic scenario is concerning.
Read More
Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Boston Scientific Corporation (NYSE:BSX ) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Company Participants Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - Executive Vice President, MedSurg and APAC Conference Call Participants Josh Jennings - TD Cowen Josh Jennings Good morning. I'm Josh Jennings from the TD Cowen Medical Devices research team, and joined by Brian Kennedy and Eric Anderson, and we're excited to kick off Day 2 of the 45th Annual TD Cowen Healthcare Conference and thrilled to have executives from the Boston Scientific management team joining us …
Read More
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Balloon Catheters Patent Landscape Report" has been added to ResearchAndMarkets.com's offering.
Read More
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Boston Scientific (BSX) and Abivax SA Sponsored ADR (ABVX) have performed compared to their sector so far this year.
Read More
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific begins 2025 on a solid note, expecting organic revenue growth of 14% to 16% in the first quarter.
Read More
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
Published: February 19, 2025 by: PRNewsWire
Sentiment: Neutral
MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.
Read More
PBH or BSX: Which Is the Better Value Stock Right Now?
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
EMEA Expansion to Support BSX Stock Amid Fierce Competition
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
Read More
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific are included in this Analyst Blog.
Read More
Best Momentum Stocks to Buy for February 10th
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX, ENVA and CFR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 10, 2025.
Read More
New Strong Buy Stocks for February 10th
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
PFIS, BSX, ENVA, NFG and NLY have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2025.
Read More
About Boston Scientific Corporation (BSX)
- IPO Date 1992-05-19
- Website https://www.bostonscientific.com
- Industry Medical - Devices
- CEO Michael F. Mahoney
- Employees 53000